Essendant (ESND) Misses Q4 EPS by 30c

Essendant (NASDAQ: ESND) reported Q4 EPS of ($0.02), $0.30 worse than the analyst estimate of $0.28. Revenue for the quarter came in at $1.3 billion versus the consensus estimate of $1.27 billion.

GUIDANCE:

Sees FY 2017 Net Sales of flat to down 4%.

For earnings history and earnings-related data on Essendant (ESND) click here.

You May Also Be Interested In

• DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
• Barclays Upgrades Schott Pharma AG (1SXP:GR) to Overweight
• HSBC Upgrades Blue Star Limited (BLSTR:IN) to Buy